Cargando…
Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
Approximately 1 man in 6 will be diagnosed with prostate cancer during his life lifetime, and over 200,000 men in the U.S. are diagnosed with prostate cancer annually. Since the widespread adoption of PSA testing, about 60–70% of men at risk in the U.S. have had a blood test for prostate cancer. Wit...
Autores principales: | Troyer, D. A., Mubiru, J., Leach, R. J., Naylor, S. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839267/ https://www.ncbi.nlm.nih.gov/pubmed/15322319 http://dx.doi.org/10.1155/2004/509276 |
Ejemplares similares
-
Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007) -
The Promise of Biomarkers in Colorectal Cancer Detection
por: Umar, Asad, et al.
Publicado: (2004) -
Statistical Methods for Evaluating DNA Methylation as a Marker for Early Detection or Prognosis
por: Alonzo, Todd A., et al.
Publicado: (2007) -
Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI-Based Approach for Prostate Cancer
por: Grizzle, William E., et al.
Publicado: (2004) -
Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
por: Javidroozi, Mazyar, et al.
Publicado: (2012)